Spruce Biosciences, Inc.
SPRB
$0.0949
-$0.0349-26.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 15.78% | -62.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 15.78% | -62.61% | |||
| Cost of Revenue | 227.39% | -18.99% | |||
| Gross Profit | -248.79% | 8.15% | |||
| SG&A Expenses | -4.11% | -2.81% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 147.46% | -14.05% | |||
| Operating Income | -155.89% | 6.26% | |||
| Income Before Tax | -171.70% | 5.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -171.70% | 5.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -171.70% | 5.55% | |||
| EBIT | -155.89% | 6.26% | |||
| EBITDA | -156.07% | 6.25% | |||
| EPS Basic | -170.46% | 5.87% | |||
| Normalized Basic EPS | -170.43% | 5.88% | |||
| EPS Diluted | -170.46% | 5.87% | |||
| Normalized Diluted EPS | -170.43% | 5.88% | |||
| Average Basic Shares Outstanding | 0.47% | 0.34% | |||
| Average Diluted Shares Outstanding | 0.47% | 0.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||